Vitamin D and its major metabolites: Serum levels after graded oral dosing in healthy men

M. J. Barger-Lux, R. P. Heaney, S. Dowell, T. C. Chen, M. F. Holick

Research output: Contribution to journalArticle

240 Citations (Scopus)

Abstract

We determined the quantitative relationships between graded oral dosing with vitamin D3, 25(OH)D3, and 1,25(OH)2D3 for short treatment periods and changes in circulating levels of these substances. The subjects were 116 healthy men (mean age, 28 ± 4 years, with usual milk consumption of ≤ 0.47 l/day and mean serum 25(OH)D of 67 ± 25 nmol/l). They were distributed among nine open-label treatment groups: vitamin D3 (25, 250 or 1250 μg/day for 8 weeks), 25(OH)D3 (10, 20 or 50 μg/day for 4 weeks) and 1,25(OH)2D3 (0.5, 1.0 or 1.0 μg/day for 2 weeks). All treatment occurred between January 3 and April 3. We measured fasting serum calcium, parathyroid hormone, vitamin D3, 25(OH)D and 1,25(OH)2D immediately before and after treatment. In the three groups treated with vitamin D3, mean values for circulating vitamin D3 increased by 13, 137 and 883 nmol/l and serum 25(OH)D increased by 29, 146 and 643 nmol/l for the three dosage groups, respectively. Treatment with 25(OH)D3 increased circulating 25(OH)D by 40, 76 and 206 nmol/l, respectively. Neither compound changed serum 1,25(OH)2D levels. However, treatment with 1,25(OH)2D3 increased circulating 1,25(OH)2D by 10, 46 and 60 pmol/l, respectively. Slopes calculated from these data allow the following estimates of mean treatment effects for typical dosage units in healthy 70-kg adults: an 8-week course of vitamin D3 at 10 μg/day (400 IU/day) would raise serum vitamin D by 9 nmol/l and serum 25(OH)D by 11 nmol/l; a 4-week course of 25(OH)D3 at 20 μg/day would raise serum 25(OH)D by 94 nmol/l; and a 2-week course of 1,25(OH)2D3 at 0.5 μg/day would raise serum 1,25(OH)2D by 17 pmol/l.

Original languageEnglish
Pages (from-to)222-230
Number of pages9
JournalOsteoporosis International
Volume8
Issue number3
DOIs
StatePublished - 1998

Fingerprint

Vitamin D
Cholecalciferol
Serum
Therapeutics
Parathyroid Hormone
Fasting
Milk
Calcium

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Barger-Lux, M. J., Heaney, R. P., Dowell, S., Chen, T. C., & Holick, M. F. (1998). Vitamin D and its major metabolites: Serum levels after graded oral dosing in healthy men. Osteoporosis International, 8(3), 222-230. https://doi.org/10.1007/s001980050058

Vitamin D and its major metabolites : Serum levels after graded oral dosing in healthy men. / Barger-Lux, M. J.; Heaney, R. P.; Dowell, S.; Chen, T. C.; Holick, M. F.

In: Osteoporosis International, Vol. 8, No. 3, 1998, p. 222-230.

Research output: Contribution to journalArticle

Barger-Lux, M. J. ; Heaney, R. P. ; Dowell, S. ; Chen, T. C. ; Holick, M. F. / Vitamin D and its major metabolites : Serum levels after graded oral dosing in healthy men. In: Osteoporosis International. 1998 ; Vol. 8, No. 3. pp. 222-230.
@article{a78693af710e4867a7205e788b5b1be8,
title = "Vitamin D and its major metabolites: Serum levels after graded oral dosing in healthy men",
abstract = "We determined the quantitative relationships between graded oral dosing with vitamin D3, 25(OH)D3, and 1,25(OH)2D3 for short treatment periods and changes in circulating levels of these substances. The subjects were 116 healthy men (mean age, 28 ± 4 years, with usual milk consumption of ≤ 0.47 l/day and mean serum 25(OH)D of 67 ± 25 nmol/l). They were distributed among nine open-label treatment groups: vitamin D3 (25, 250 or 1250 μg/day for 8 weeks), 25(OH)D3 (10, 20 or 50 μg/day for 4 weeks) and 1,25(OH)2D3 (0.5, 1.0 or 1.0 μg/day for 2 weeks). All treatment occurred between January 3 and April 3. We measured fasting serum calcium, parathyroid hormone, vitamin D3, 25(OH)D and 1,25(OH)2D immediately before and after treatment. In the three groups treated with vitamin D3, mean values for circulating vitamin D3 increased by 13, 137 and 883 nmol/l and serum 25(OH)D increased by 29, 146 and 643 nmol/l for the three dosage groups, respectively. Treatment with 25(OH)D3 increased circulating 25(OH)D by 40, 76 and 206 nmol/l, respectively. Neither compound changed serum 1,25(OH)2D levels. However, treatment with 1,25(OH)2D3 increased circulating 1,25(OH)2D by 10, 46 and 60 pmol/l, respectively. Slopes calculated from these data allow the following estimates of mean treatment effects for typical dosage units in healthy 70-kg adults: an 8-week course of vitamin D3 at 10 μg/day (400 IU/day) would raise serum vitamin D by 9 nmol/l and serum 25(OH)D by 11 nmol/l; a 4-week course of 25(OH)D3 at 20 μg/day would raise serum 25(OH)D by 94 nmol/l; and a 2-week course of 1,25(OH)2D3 at 0.5 μg/day would raise serum 1,25(OH)2D by 17 pmol/l.",
author = "Barger-Lux, {M. J.} and Heaney, {R. P.} and S. Dowell and Chen, {T. C.} and Holick, {M. F.}",
year = "1998",
doi = "10.1007/s001980050058",
language = "English",
volume = "8",
pages = "222--230",
journal = "Osteoporosis International",
issn = "0937-941X",
publisher = "Springer London",
number = "3",

}

TY - JOUR

T1 - Vitamin D and its major metabolites

T2 - Serum levels after graded oral dosing in healthy men

AU - Barger-Lux, M. J.

AU - Heaney, R. P.

AU - Dowell, S.

AU - Chen, T. C.

AU - Holick, M. F.

PY - 1998

Y1 - 1998

N2 - We determined the quantitative relationships between graded oral dosing with vitamin D3, 25(OH)D3, and 1,25(OH)2D3 for short treatment periods and changes in circulating levels of these substances. The subjects were 116 healthy men (mean age, 28 ± 4 years, with usual milk consumption of ≤ 0.47 l/day and mean serum 25(OH)D of 67 ± 25 nmol/l). They were distributed among nine open-label treatment groups: vitamin D3 (25, 250 or 1250 μg/day for 8 weeks), 25(OH)D3 (10, 20 or 50 μg/day for 4 weeks) and 1,25(OH)2D3 (0.5, 1.0 or 1.0 μg/day for 2 weeks). All treatment occurred between January 3 and April 3. We measured fasting serum calcium, parathyroid hormone, vitamin D3, 25(OH)D and 1,25(OH)2D immediately before and after treatment. In the three groups treated with vitamin D3, mean values for circulating vitamin D3 increased by 13, 137 and 883 nmol/l and serum 25(OH)D increased by 29, 146 and 643 nmol/l for the three dosage groups, respectively. Treatment with 25(OH)D3 increased circulating 25(OH)D by 40, 76 and 206 nmol/l, respectively. Neither compound changed serum 1,25(OH)2D levels. However, treatment with 1,25(OH)2D3 increased circulating 1,25(OH)2D by 10, 46 and 60 pmol/l, respectively. Slopes calculated from these data allow the following estimates of mean treatment effects for typical dosage units in healthy 70-kg adults: an 8-week course of vitamin D3 at 10 μg/day (400 IU/day) would raise serum vitamin D by 9 nmol/l and serum 25(OH)D by 11 nmol/l; a 4-week course of 25(OH)D3 at 20 μg/day would raise serum 25(OH)D by 94 nmol/l; and a 2-week course of 1,25(OH)2D3 at 0.5 μg/day would raise serum 1,25(OH)2D by 17 pmol/l.

AB - We determined the quantitative relationships between graded oral dosing with vitamin D3, 25(OH)D3, and 1,25(OH)2D3 for short treatment periods and changes in circulating levels of these substances. The subjects were 116 healthy men (mean age, 28 ± 4 years, with usual milk consumption of ≤ 0.47 l/day and mean serum 25(OH)D of 67 ± 25 nmol/l). They were distributed among nine open-label treatment groups: vitamin D3 (25, 250 or 1250 μg/day for 8 weeks), 25(OH)D3 (10, 20 or 50 μg/day for 4 weeks) and 1,25(OH)2D3 (0.5, 1.0 or 1.0 μg/day for 2 weeks). All treatment occurred between January 3 and April 3. We measured fasting serum calcium, parathyroid hormone, vitamin D3, 25(OH)D and 1,25(OH)2D immediately before and after treatment. In the three groups treated with vitamin D3, mean values for circulating vitamin D3 increased by 13, 137 and 883 nmol/l and serum 25(OH)D increased by 29, 146 and 643 nmol/l for the three dosage groups, respectively. Treatment with 25(OH)D3 increased circulating 25(OH)D by 40, 76 and 206 nmol/l, respectively. Neither compound changed serum 1,25(OH)2D levels. However, treatment with 1,25(OH)2D3 increased circulating 1,25(OH)2D by 10, 46 and 60 pmol/l, respectively. Slopes calculated from these data allow the following estimates of mean treatment effects for typical dosage units in healthy 70-kg adults: an 8-week course of vitamin D3 at 10 μg/day (400 IU/day) would raise serum vitamin D by 9 nmol/l and serum 25(OH)D by 11 nmol/l; a 4-week course of 25(OH)D3 at 20 μg/day would raise serum 25(OH)D by 94 nmol/l; and a 2-week course of 1,25(OH)2D3 at 0.5 μg/day would raise serum 1,25(OH)2D by 17 pmol/l.

UR - http://www.scopus.com/inward/record.url?scp=0031671011&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031671011&partnerID=8YFLogxK

U2 - 10.1007/s001980050058

DO - 10.1007/s001980050058

M3 - Article

C2 - 9797906

AN - SCOPUS:0031671011

VL - 8

SP - 222

EP - 230

JO - Osteoporosis International

JF - Osteoporosis International

SN - 0937-941X

IS - 3

ER -